Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-02-24

    Virtual Booth

    Contact Supplier

    Menu

    Alteplase

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genentech's Biologic Activase (Alteplase) Receives Approval in the U.S.
    Genentech's Biologic Activase (Alteplase) Receives Approval in the U.S.

    01 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103172

    FDA
    01 Sep 2022
    Share Share
    Boehringer Ingelheim Focuses COVID-19 Clinical Research on Alteplase
    Boehringer Ingelheim Focuses COVID-19 Clinical Research on Alteplase

    26 Jul 2021

    // PRESS RELEASE

    https://www.boehringer-ingelheim.com/press-release/bi-focuses-covid-19-clinical-research-alteplase

    PRESS RELEASE
    26 Jul 2021
    Share Share
    Boehringer Ingelheim Focuses COVID-19 Clinical Research on Alteplase
    Boehringer Ingelheim Focuses COVID-19 Clinical Research on Alteplase

    26 Jul 2021

    // PRESS RELEASE

    https://www.boehringer-ingelheim.com/press-release/bi-focuses-covid-19-clinical-research-alteplase

    PRESS RELEASE
    26 Jul 2021
    Share Share
    Enforcement Report - Week of May 1, 2019
    Enforcement Report - Week of May 1, 2019

    01 May 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-1-2019-1556686753.pdf

    FDA
    01 May 2019
    Share Share